Practice Areas:
Investment funds
Jurisdictions:
Recent transactional highlights
- Advised Curon Biopharmaceutical on its US$150 million Series A financing, led by 6 Dimensions, Temasek and Boyu
- Advised IDG on the formation of semiconductor and AI merger fund (Yiwu Jinhong Fund). This fund has raised RMB10.8 billion and is still in the process of fundraising.
- Advised client during the whole process of the formation of the Beijing Fund (the “Fund”) jointly established by Tishman Speyer and Shougang Fund. Matter value is about RMB1.8 billion
- Advised Lilly Asia Ventures on the merger of its portpolios, Hangzhou Just Biotherapeutics and MabSpace Biosciences to create Transcenta Holding Ltd., a world-class biotherapeutics company.
Practice areas
- Investment funds
- Private equity
Sector specialisations
- Financial services
- Healthcare
- Investment management
- Pharma and life sciences
Bar admissions
- PRC Admitted Lawyer
Association memberships
- Secretary General, CEIBS Alumni PE Association Shanghai
- Member, Shanghai Bar Association Fund Research Committee
- Mediator, Shanghai Pudong Professional Mediation Center
- Co-chair, Fund Asset Backed Securitization Committee of China Asset Backed Securitization Forum
Academic qualifications
- LL.M. (East China Univ. of Political Science and Law)
- LL.B. (East China Univ. of Political Science and Law)
- EMBA (China Europe International Business School)
Address:
Tel:+86 21 6061 3599
Email:Contact this practitioner
Website:http://www.zhonglun.com/Content/2016/10-14/1643210109.html
Shanghai